Hadis Honarvar

1.0k total citations
30 papers, 861 citations indexed

About

Hadis Honarvar is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Hadis Honarvar has authored 30 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Hadis Honarvar's work include Monoclonal and Polyclonal Antibodies Research (25 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Glycosylation and Glycoproteins Research (6 papers). Hadis Honarvar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (25 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Glycosylation and Glycoproteins Research (6 papers). Hadis Honarvar collaborates with scholars based in Sweden, Iran and Italy. Hadis Honarvar's co-authors include Vladimir Tolmachev, Anna Orlova, Amelie Eriksson Karlström, Mohamed Altai, Joanna Strand, Kristina Westerlund, Bogdan Mitran, Mattias Sandström, Javad Garousi and Anna Perols and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Hadis Honarvar

29 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadis Honarvar Sweden 20 698 404 309 96 73 30 861
Daniel Rosik Sweden 15 931 1.3× 459 1.1× 437 1.4× 90 0.9× 50 0.7× 17 1.1k
Anzhelika Vorobyeva Sweden 20 799 1.1× 499 1.2× 330 1.1× 122 1.3× 39 0.5× 73 1.0k
Mohamed Altai Sweden 23 1.1k 1.5× 580 1.4× 425 1.4× 151 1.6× 134 1.8× 42 1.3k
Helena Wållberg Sweden 18 859 1.2× 462 1.1× 305 1.0× 88 0.9× 25 0.3× 26 978
Eftychia Koumarianou United States 13 618 0.9× 288 0.7× 203 0.7× 178 1.9× 37 0.5× 20 710
Javad Garousi Sweden 22 790 1.1× 485 1.2× 285 0.9× 146 1.5× 34 0.5× 58 1.1k
Sara S. Rinne Sweden 19 541 0.8× 351 0.9× 202 0.7× 158 1.6× 19 0.3× 44 676
Conrad Chan Canada 16 504 0.7× 261 0.6× 213 0.7× 158 1.6× 37 0.5× 32 772
Thorsten Poethko Germany 16 847 1.2× 266 0.7× 247 0.8× 99 1.0× 123 1.7× 21 1.2k
Nellie K. Owen United States 16 766 1.1× 409 1.0× 285 0.9× 206 2.1× 57 0.8× 24 992

Countries citing papers authored by Hadis Honarvar

Since Specialization
Citations

This map shows the geographic impact of Hadis Honarvar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadis Honarvar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadis Honarvar more than expected).

Fields of papers citing papers by Hadis Honarvar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadis Honarvar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadis Honarvar. The network helps show where Hadis Honarvar may publish in the future.

Co-authorship network of co-authors of Hadis Honarvar

This figure shows the co-authorship network connecting the top 25 collaborators of Hadis Honarvar. A scholar is included among the top collaborators of Hadis Honarvar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadis Honarvar. Hadis Honarvar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Honarvar, Hadis, Mark Lubberink, Håkan Jorulf, et al.. (2020). Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [11C]-Acetate PET/CT. International Journal of Medical Sciences. 17(2). 214–223. 5 indexed citations
2.
Honarvar, Hadis, Enrica Calce, Nunzianna Doti, et al.. (2018). Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe. Scientific Reports. 8(1). 2998–2998. 25 indexed citations
3.
4.
Garousi, Javad, Sarah Lindbo, Hadis Honarvar, et al.. (2016). Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6. Bioconjugate Chemistry. 27(11). 2678–2688. 15 indexed citations
5.
Honarvar, Hadis, Cristina Müller, Susan Cohrs, et al.. (2016). Evaluation of the first 44Sc-labeled Affibody molecule for imaging of HER2-expressing tumors. Nuclear Medicine and Biology. 45. 15–21. 31 indexed citations
6.
Westerlund, Kristina, Hadis Honarvar, Joanna Strand, et al.. (2016). Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules. Molecular Pharmaceutics. 13(5). 1668–1678. 40 indexed citations
7.
Honarvar, Hadis, Kristina Westerlund, Mattias Sandström, et al.. (2015). Feasibility of Affibody molecule-based PNA-mediated pretargeting. European Journal of Nuclear Medicine and Molecular Imaging. 42. 1 indexed citations
8.
Garousi, Javad, Sarah Lindbo, Johan Nilvebrant, et al.. (2015). ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers. Cancer Research. 75(20). 4364–4371. 53 indexed citations
9.
Westerlund, Kristina, Hadis Honarvar, Vladimir Tolmachev, & Amelie Eriksson Karlström. (2015). Design, Preparation, and Characterization of PNA-Based Hybridization Probes for Affibody-Molecule-Mediated Pretargeting. Bioconjugate Chemistry. 26(8). 1724–1736. 32 indexed citations
10.
Altai, Mohamed, Anna Perols, Bogdan Mitran, et al.. (2015). Feasibility of Affibody-Based Bioorthogonal Chemistry–Mediated Radionuclide Pretargeting. Journal of Nuclear Medicine. 57(3). 431–436. 50 indexed citations
11.
Honarvar, Hadis, Kristina Westerlund, Mattias Sandström, et al.. (2015). Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors. Theranostics. 6(1). 93–103. 52 indexed citations
12.
Garousi, Javad, Sarah Lindbo, Anna Orlova, et al.. (2014). Development of ADAPT6 as a new scaffold protein for radionuclide molecular imaging. European Journal of Nuclear Medicine and Molecular Imaging. 41.
13.
Altai, Mohamed, Helena Wållberg, Hadis Honarvar, et al.. (2014). 188Re-ZHER2:V2, a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment. Journal of Nuclear Medicine. 55(11). 1842–1848. 23 indexed citations
14.
Altai, Mohamed, Hadis Honarvar, Helena Wållberg, et al.. (2014). Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re. European Journal of Medicinal Chemistry. 87. 519–528. 19 indexed citations
15.
Mitran, Bogdan, Mohamed Altai, Camilla Hofström, et al.. (2014). Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression. Amino Acids. 47(2). 303–315. 22 indexed citations
16.
Strand, Joanna, Hadis Honarvar, Anna Perols, et al.. (2013). Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts. PLoS ONE. 8(8). e70028–e70028. 50 indexed citations
17.
Honarvar, Hadis, Karl Andersson, Jennie Malmberg, et al.. (2013). Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging. Nuclear Medicine and Biology. 40(3). 378–386. 16 indexed citations
18.
Honarvar, Hadis, Anna Perols, Joanna Strand, et al.. (2012). Influence of DOTA chelator position on biodistribution and targeting properties of 111 In-labelled anti-HER2 affibody molecules. European Journal of Nuclear Medicine and Molecular Imaging. 39. 1 indexed citations
19.
Perols, Anna, Hadis Honarvar, Joanna Strand, et al.. (2012). Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of 111In-Labeled Synthetic Anti-HER2 Affibody Molecules. Bioconjugate Chemistry. 23(8). 1661–1670. 38 indexed citations
20.
Sajjadi, Moosa, et al.. (2010). COMPARISON OF MEROCEL AND REGULAR TAMPON REGARDING COMFORT AND PROBLEMS OF PATIENTS AFTER SEPTO-RHINOPLASTY SURGERY. Journal of Birjand University of Medical Sciences. 17(445). 249–255. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Rosik Breakdown of academic impact, for papers by Anzhelika Vorobyeva Breakdown of academic impact, for papers by Mohamed Altai Breakdown of academic impact, for papers by Helena Wållberg Breakdown of academic impact, for papers by Eftychia Koumarianou Breakdown of academic impact, for papers by Javad Garousi Breakdown of academic impact, for papers by Sara S. Rinne Breakdown of academic impact, for papers by Conrad Chan Breakdown of academic impact, for papers by Thorsten Poethko Breakdown of academic impact, for papers by Nellie K. Owen
Rankless by CCL
2026